Bixiye
QP34-25 MHCP Pharmacy Benefit Exclusion for Grafapex™, Ivra and Selarsdi™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 331 - 340 ee natiijooyinka 3167
Bixiye
QP33-25 Commercial Pharmacy Benefit Exclusion for Bkemv™, Otulfi™, Pyzchiva®, Selarsdi™ and Ustekinumab-ttwe™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
QP32-25 Cotiviti to Begin Preventable Readmission Audits
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
QP31-25 Peer-to-Peer Discussions for Denied Claims Ending
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025